Skip to main content
. 2022 Sep 10;20:99. doi: 10.1186/s12961-022-00883-6

Table 3.

Examples of types of funding announcements illustrating various points most relevant for the lessons (e.g. rapid call, minorities, other topics)

Date Country/funder Topic/title of programme Amount in local currency USD GBP EUR
Combined spending plans
March 2020 Canadian federal government [132] Press release: Canada’s plan to mobilize science to fight COVID-19 Can$ 275 million 200 million 162 million 180 million
April 2020 Canadian federal government [90] Press release: PM announces new support for COVID-19 medical research and vaccine development Can$ 1billion+ 0.73 billion+ 0.6 billion 0.65 billion
Rapid/early funding
Feb 2020 UK: NIHR/UK Research and Innovation (MRC) [133] Novel coronavirus research: (1) vaccines and therapeutics; (2) diagnostics and epidemiology, spread, containment, basic knowledge £20 million 25 million 20 million 22 million
Feb 2020 Canada: CIHR and other research councils [115] Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding

Can$ 7 million

(ended up Can$ 55 million)

5 million

(40 million)

4 million (32 million)

4.6 million

(36 million)

Feb 2020 New Zealand: HRC/Ministry of Health [134] Government agencies launch rapid research response to COVID-19 threat NZ$ 3 million 1.9 million 1.5 million 1.7 million
April 2020 Brazil: National Council for Scientific and Technological Development [135] COVID-19 treatment, vaccine, diagnosis, pathogenesis and natural history of the disease, disease burden, attention to health, prevention, and control R$ 49 million 9.2 million 7.4 million 8.3 million
Initial funding—indigenous/minority populations
March 2020 Australia: Paul Ramsay Foundation [116] Support for APPRISE COVID-19 research with First Nations Peoples (part of Foundation’s A$ 9 million initial COVID programme) A$ 2 million 1.3 million 1.2 million 1.2 million
Aug 2020 New Zealand: HRC [111] Māori-led part of 2020 COVID-19 Equity Response (Total NZ$ 8 million) NZ$ 3 million 1.9 million 1.5 million 1.7 million
Sept 2020 Canada: CIHR [118] Indigenous COVID-19 Rapid Research Funding Opportunity Can$ 2 million 1.5 million 1.2 million 1.3 million
Sept 2020 USA: NIH [120] Rapid Acceleration of Diagnostics (RADx) Underserved Populations (first allocations to 32 institutions—part of US$ 1.5 billion RADx initiative begun in late April 2020) US$ 234 (up to US$ 512 million by Nov 2021) [136] 234 million

189 million

(414 million)

210 million

(460 million)

International/networks
March 2020 UK: government [137] Press release: PM announces record funding to find a coronavirus vaccine—donation to CEPI £210 million 260 million 210 million 233 million
Oct 2020 Germany: Federal Ministry of Education and Research [94] Funding of 13 projects in the National Research Network of University Medicine (network had been established in spring 2020) €150 million 167 million 135 million 150 million
Subnational organization
March 2020 Brazil: Rio de Janeiro state government [135] Rio de Janeiro State Research Support Foundation—COVID-19 research programme R$ 24.6 million 4.6 million 3.7 million 4.1 million
April 2020 Australia: NSW Government [113] NSW Health COVID-19 Research Program—various streams A$ 25 million 16.7 million 13.5 million 15 million
Public/private sector collaborations
May 2020 US federal government [59] Operation Warp Speed: public (multi-agency)/private collaboration: develop and manufacture new vaccines and drugs US$ 10 billion (ended up higher) 10 billion 9 billion 8.1 billion
Sept 2020 Germany: Federal Ministry of Education and Research [138] Funding to BioNTech (part of €750 million to three companies) to support development and production capacity for COVID-19 vaccines €445 million 496 million 401 million 445 million

Currency equivalents as at end of May 2020